Aeluma to Participate in 38th Annual ROTH Conference
Rhea-AI Summary
Aeluma (NASDAQ: ALMU) announced that CEO Jonathan Klamkin, Ph.D., and CFO Christopher Stewart will attend the 38th Annual ROTH Conference on March 23, 2026 in Dana Point, California at the Ritz-Carlton Laguna Niguel.
The management team will hold one-on-ones and small group meetings with analysts and investors; investors should contact ROTH Capital Partners to register or request meetings.
Positive
- None.
Negative
- None.
News Market Reaction – ALMU
On the day this news was published, ALMU declined 2.20%, reflecting a moderate negative market reaction. Argus tracked a trough of -13.5% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $7M from the company's valuation, bringing the market cap to $295M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
ALMU showed a notable move while peers were mixed: some, like SQNS (10.95%), traded higher, while others, such as WOLF (-1.02%), traded lower, pointing to stock-specific dynamics rather than a unified semiconductor sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 11 | Earnings release | Neutral | -8.4% | Q2 FY2026 results with losses but reaffirmed revenue guidance and progress. |
| Feb 10 | Leadership hire | Positive | +11.6% | New SVP to lead go-to-market across key photonics markets. |
| Jan 28 | Earnings date set | Neutral | +0.1% | Announcement of Q2 FY2026 release date and conference call details. |
| Dec 10 | Investor event | Positive | +2.9% | Fireside chat highlighting patents, MMEC membership, and NASA contract. |
| Dec 09 | Patent filing | Positive | +6.3% | New patent application expanding portfolio to 35 issued and pending patents. |
Operational and IP/news events have often coincided with positive or flat moves, while the latest earnings release saw a notable negative reaction.
Over the last few months, Aeluma reported Q2 FY2026 results on Feb 11, 2026, with shares falling 8.43% despite reaffirmed revenue guidance and commercialization progress. A senior business development hire on Feb 10, 2026 coincided with an 11.61% gain, while an earlier earnings-date announcement on Jan 28, 2026 saw little movement. December 2025 news on patents and a fireside chat, highlighting NASA work and expanded IP, corresponded with gains of 2.87% and 6.28%. Today’s conference participation fits this pattern of visibility-focused news.
Regulatory & Risk Context
Aeluma has an effective S-3/A shelf registration dated 2025-08-06, expiring 2028-08-06, with at least 6 recorded usages, including recent 424B3 filings. Specific capacity and remaining availability are not provided.
Market Pulse Summary
This announcement highlights Aeluma’s participation in the 38th Annual ROTH Conference on March 23, 2026, offering management additional visibility with analysts and investors. Historically, investor-focused events and IP updates have often coincided with constructive stock responses, while earnings have produced more mixed reactions. Recent SEC filings show active capital markets activity and insider sales, alongside an effective S-3/A shelf registration. Going forward, investors may watch for execution on commercialization milestones, future filings, and subsequent corporate updates following the conference.
AI-generated analysis. Not financial advice.
GOLETA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that its CEO Jonathan Klamkin, Ph.D., and CFO Christopher Stewart will participate in the 38th Annual ROTH Conference on March 23, 2026 in Dana Point, California at the Ritz-Carlton Laguna Niguel. The management team will participate in one-on-ones and small group meetings with analysts and investors.
For more information about this conference and for registration information, please contact ROTH Capital Partners. Any investors interested in meeting with Aeluma management at the conference should contact their representatives at ROTH.
About Aeluma
Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.
Company:
Aeluma, Inc.
(805) 351-2707
info@aeluma.com
Investor Contact:
Financial Profiles, Inc.
Moira Conlon and Alex Villalta
(310) 622-8227
ir@aeluma.com
FAQ
When will Aeluma (ALMU) management present at the 38th Annual ROTH Conference?
Who from Aeluma (ALMU) will attend the ROTH Conference and what roles will they perform?
How can investors schedule a meeting with Aeluma (ALMU) at the ROTH Conference?
Where is the 38th Annual ROTH Conference taking place for Aeluma (ALMU) meetings?
What topics will Aeluma (ALMU) likely cover in its ROTH Conference meetings?
